Reversal of enoxaparin-induced anticoagulation in healthy subjects by andexanet alfa (PRT064445), an antidote for direct and indirect fXa inhibitors – a phase 2 randomized, double-blind, placebo-controlled trial. J Thromb Haemost - Crowther, M (2014)
Abstract COA01.